Cargando…

Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer

Background and Objectives: Currently, the United States Joint Commission on Cancer (AJCC) N staging, lymph node positive rate (LNR), and log odds of positive lymph nodes (LODDS) are the main lymph node (LN) staging systems. However, the type of LN staging system that is more accurate in terms of pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Jun-Peng, Zhang, Chun-Dong, Fan, Yu-Chen, Dai, Dong-Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340930/
https://www.ncbi.nlm.nih.gov/pubmed/30697530
http://dx.doi.org/10.3389/fonc.2018.00671
_version_ 1783388857532678144
author Pei, Jun-Peng
Zhang, Chun-Dong
Fan, Yu-Chen
Dai, Dong-Qiu
author_facet Pei, Jun-Peng
Zhang, Chun-Dong
Fan, Yu-Chen
Dai, Dong-Qiu
author_sort Pei, Jun-Peng
collection PubMed
description Background and Objectives: Currently, the United States Joint Commission on Cancer (AJCC) N staging, lymph node positive rate (LNR), and log odds of positive lymph nodes (LODDS) are the main lymph node (LN) staging systems. However, the type of LN staging system that is more accurate in terms of prognostic performance remains controversial. We compared the prognostic accuracy of the three staging systems in patients with CRC and determine the best choice for clinical applications. Methods: From the Surveillance, Epidemiology, and End Results (SEER) database, 56,747 patients were identified who were diagnosed with CRC between 2004 and 2013. Akaike's Information Criterion (AIC) and Harrell's Consistency Index (c-index) were used to assess the relative discriminative abilities of different LN staging systems. Results: In 56,747 patients, when using classification cut-off values for evaluation, the LNR of Rosenberg et al. showed significantly better predictive power, especially when the number of dissected lymph nodes (NDLN) were insufficient. When analyzed as a continuous variable, the LODDS staging system performed the best and was not affected by the NDLN. Conclusions: We suggest that the LNR of Rosenberg et al. should be introduced into the AJCC system as a supplement when the NDLN is insufficient until the optimal LODDS cut-off values are calculated.
format Online
Article
Text
id pubmed-6340930
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63409302019-01-29 Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer Pei, Jun-Peng Zhang, Chun-Dong Fan, Yu-Chen Dai, Dong-Qiu Front Oncol Oncology Background and Objectives: Currently, the United States Joint Commission on Cancer (AJCC) N staging, lymph node positive rate (LNR), and log odds of positive lymph nodes (LODDS) are the main lymph node (LN) staging systems. However, the type of LN staging system that is more accurate in terms of prognostic performance remains controversial. We compared the prognostic accuracy of the three staging systems in patients with CRC and determine the best choice for clinical applications. Methods: From the Surveillance, Epidemiology, and End Results (SEER) database, 56,747 patients were identified who were diagnosed with CRC between 2004 and 2013. Akaike's Information Criterion (AIC) and Harrell's Consistency Index (c-index) were used to assess the relative discriminative abilities of different LN staging systems. Results: In 56,747 patients, when using classification cut-off values for evaluation, the LNR of Rosenberg et al. showed significantly better predictive power, especially when the number of dissected lymph nodes (NDLN) were insufficient. When analyzed as a continuous variable, the LODDS staging system performed the best and was not affected by the NDLN. Conclusions: We suggest that the LNR of Rosenberg et al. should be introduced into the AJCC system as a supplement when the NDLN is insufficient until the optimal LODDS cut-off values are calculated. Frontiers Media S.A. 2019-01-15 /pmc/articles/PMC6340930/ /pubmed/30697530 http://dx.doi.org/10.3389/fonc.2018.00671 Text en Copyright © 2019 Pei, Zhang, Fan and Dai. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Pei, Jun-Peng
Zhang, Chun-Dong
Fan, Yu-Chen
Dai, Dong-Qiu
Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer
title Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer
title_full Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer
title_fullStr Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer
title_full_unstemmed Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer
title_short Comparison of Different Lymph Node Staging Systems in Patients With Resectable Colorectal Cancer
title_sort comparison of different lymph node staging systems in patients with resectable colorectal cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340930/
https://www.ncbi.nlm.nih.gov/pubmed/30697530
http://dx.doi.org/10.3389/fonc.2018.00671
work_keys_str_mv AT peijunpeng comparisonofdifferentlymphnodestagingsystemsinpatientswithresectablecolorectalcancer
AT zhangchundong comparisonofdifferentlymphnodestagingsystemsinpatientswithresectablecolorectalcancer
AT fanyuchen comparisonofdifferentlymphnodestagingsystemsinpatientswithresectablecolorectalcancer
AT daidongqiu comparisonofdifferentlymphnodestagingsystemsinpatientswithresectablecolorectalcancer